Sitka Biopharma

Transforming chemotherapies to further benefit patients by enhancing efficacy and improving tolerability.

Launch date

2013

Employees

Market cap

Enterprise valuation

Vancouver British Columbia (HQ)

Date	Investors	Amount	Round
-	AdMare BioInnovations	N/A	-
Jan 2013	The University of British Columbia	N/A	Spinout
Jan 2015	Accel-Rx Health Sciences Accelerator	N/A	Seed
Apr 2016	Quark Venture	N/A	Seed
Aug 2016	Quark Venture	$2.4m	Seed
Aug 2017	Quark Venture	$2.4m	Seed
Oct 2018	GF Securities Quark Venture	$1.9m	Early VC
Feb 2019	Centre for Drug Research and Development	$1.2m	Early VC
Total Funding		$7.9m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Sitka Biopharma